Dyve Biosciences, in collaboration with Moffitt Cancer Center, today reported significant study results for a ...

Fred Hutch Cancer Center molecular biologist Dr. Kevin Barry just received a $270,000, two-year grant from the American ...

Epicutis®, the professional skincare brand powered by patented biotechnology from Signum Biosciences, today announced the launch of Hydrobiome Serum ? a next-generation formulation that redefines how ...

NIQ (the "Company", or "NIQ"), a leading global consumer intelligence company, plans to report its financial results for the first quarter ended March 31, 2026, on Thursday, May 14, 2026. The Company ...

Why don't humans grow new brain cells? A new study shows "tunneling" neurons in songbirds may explain our limited capacity ...

Researchers suggest tunneling may reflect a conserved strategy adopted by specialized migratory cell types in dense tissues.

Is One Still Ahead for Evotec? Bayer has had some turbulent years. That is no secret. Anyone who invested in the Leverkusen-based company needed strong nerves and patience. But the tide appears to ...

Determining the presence of a protein in non-tumor cells within the cancer microenvironment could be one of the keys to ...

A new study has identified a molecular guardian that keeps skin cells from forgetting what they are and transforming into ...

Researchers are launching a new project to crack the mystery of aggressive breast cancer, where predicting disease ...

Despite major advances in targeted therapies, immunotherapies, and combination regimens, therapy resistance remains a central barrier to durable cancer ...